FIELD: medicine, narcology, biochemistry, pharmacy.
SUBSTANCE: invention proposes using the combination of dextromethorphan and the second medicine (quinidine, yohimbin, haloperdol, adjmaline, lobeline, pipamperon, fluoxetine, labetalol, chlorpromazine, domperidone, nortryptiline, quinine, oxyprenolol, propranolol, timolol, methaprolol, diphenhydramine, papaverine, mexiletine or their salts or isomers) for removing addiction to opiates, opioids or synthetic narcotics with exception cocaine and barbiturates (help in refusal in their using) or in case of chronic using antidepressant and corresponding treatment methods. The proposed combination of drugs reduces pain and relieves the withdrawal syndrome on the background of reducing morphine dose (antidepressant) up to the complete removing their intake.
EFFECT: enhanced effectiveness and valuable medicinal properties of medicine combinations.
54 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS FOR NEURAL DISORDER TREATMENT, CONTAINING DEXTROMETHORPHANE AND QUINIDINE | 2003 |
|
RU2341265C2 |
| GENOTYPE- OR PHENOTYPE-BASED DRUG FORMULATION | 2013 |
|
RU2683260C2 |
| PHARMACEUTICAL TABLET | 2003 |
|
RU2273473C2 |
| METHOD OF NARCOMANIA TREATMENT | 2000 |
|
RU2197250C2 |
| COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2017 |
|
RU2764716C2 |
| DEXTROMETHORPHAN TRANSDERMAL DELIVERY DEVICE | 2018 |
|
RU2795729C2 |
| METHODS FOR TREATMENT OF GAUCHER DISEASE | 2018 |
|
RU2781242C2 |
| TARGET DRUG WITH NEW COMPOSITIONS, COMBINATIONS AND METHODS | 2018 |
|
RU2760558C2 |
| COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID | 1998 |
|
RU2241458C2 |
| MEDICINAL COMBINATION COMPRISING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND INHIBITOR, INDUCTOR OR SUBSTRATE FOR P-450 3A4 ISOZYME | 2000 |
|
RU2233162C2 |
